ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients
ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay) and rilpivirine (Edurant) as maintenance therapy for...
